Flow Cytometric Assessment of Malignant Hematologic Disorders.
Clin Lab Med
; 44(3): 465-477, 2024 Sep.
Article
em En
| MEDLINE
| ID: mdl-39089752
ABSTRACT
Multiparameter flow cytometry (MPF) is an essential component of the diagnostic workup of hematologic malignancies. Recently developed tools have expanded the utility of MPF in detecting T-cell clonality and myelomonocytic dysplasia. Minimal/measurable residual disease analysis has long been established as critical in the management of B-lymphoblastic leukemia and is emerging as a useful tool in myeloid malignancies. With the continued increased complexity of MPF assays, emerging tools for data collection and analysis will allow users to take full advantage of MPF in the diagnosis of hematologic disease.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Hematológicas
/
Citometria de Fluxo
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article